Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.3.0.814
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenue - from a related party $ 25 $ 0 $ 525 $ 0
Operating expenses        
Research and development 9,073 1,609 13,172 8,473
Research and development - licenses acquired 1,895 0 10,882 0
General and administrative 7,129 2,737 14,376 7,218
Total operating expenses 18,097 4,346 38,430 15,691
Loss from operations (18,072) (4,346) (37,905) (15,691)
Other income (expenses)        
Interest income 39 168 195 517
Interest expense (350) (121) (1,033) (1,206)
Change in fair value of investments (1,472) (293) (65) (293)
Total other income (expenses) (1,783) (246) (903) (982)
Net loss (19,855) (4,592) (38,808) (16,673)
Less: net loss attributable to non-controlling interest 1,694 0 2,416 0
Net loss attributable to common stockholders $ (18,161) $ (4,592) $ (36,392) $ (16,673)
Basic and diluted net loss per common share $ (0.46) $ (0.13) $ (0.93) $ (0.46)
Weighted average common shares outstanding - basic and diluted 39,412,056 36,024,810 39,038,522 35,977,355